These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

398 related articles for article (PubMed ID: 21874282)

  • 1. Medical therapy for acute decompensated heart failure: what recent clinical trials have taught us about diuretics and vasodilators.
    Marti C; Cole R; Kalogeropoulos A; Georgiopoulou V; Butler J
    Curr Heart Fail Rep; 2012 Mar; 9(1):1-7. PubMed ID: 21874282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combining Diuretic Response and Hemoconcentration to Predict Rehospitalization After Admission for Acute Heart Failure.
    Ter Maaten JM; Valente MA; Damman K; Cleland JG; Givertz MM; Metra M; O'Connor CM; Teerlink JR; Ponikowski P; Bloomfield DM; Cotter G; Davison B; Subacius H; van Veldhuisen DJ; van der Meer P; Hillege HL; Gheorghiade M; Voors AA
    Circ Heart Fail; 2016 Jun; 9(6):. PubMed ID: 27266853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Worsening Heart Failure Following Admission for Acute Heart Failure: A Pooled Analysis of the PROTECT and RELAX-AHF Studies.
    Davison BA; Metra M; Cotter G; Massie BM; Cleland JGF; Dittrich HC; Edwards C; Filippatos G; Givertz MM; Greenberg B; Ponikowski P; Voors AA; O'Connor CM; Teerlink JR;
    JACC Heart Fail; 2015 May; 3(5):395-403. PubMed ID: 25951761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relief and Recurrence of Congestion During and After Hospitalization for Acute Heart Failure: Insights From Diuretic Optimization Strategy Evaluation in Acute Decompensated Heart Failure (DOSE-AHF) and Cardiorenal Rescue Study in Acute Decompensated Heart Failure (CARESS-HF).
    Lala A; McNulty SE; Mentz RJ; Dunlay SM; Vader JM; AbouEzzeddine OF; DeVore AD; Khazanie P; Redfield MM; Goldsmith SR; Bart BA; Anstrom KJ; Felker GM; Hernandez AF; Stevenson LW
    Circ Heart Fail; 2015 Jul; 8(4):741-8. PubMed ID: 26041600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rationale and Design of the "Safety and Efficacy of the Combination of Loop with Thiazide-type Diuretics in Patients with Decompensated Heart Failure (CLOROTIC) Trial:" A Double-Blind, Randomized, Placebo-Controlled Study to Determine the Effect of Combined Diuretic Therapy (Loop Diuretics With Thiazide-Type Diuretics) Among Patients With Decompensated Heart Failure.
    Trullàs JC; Morales-Rull JL; Casado J; Freitas Ramírez A; Manzano L; Formiga F;
    J Card Fail; 2016 Jul; 22(7):529-36. PubMed ID: 26576715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short-term risk of death after treatment with nesiritide for decompensated heart failure: a pooled analysis of randomized controlled trials.
    Sackner-Bernstein JD; Kowalski M; Fox M; Aaronson K
    JAMA; 2005 Apr; 293(15):1900-5. PubMed ID: 15840865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of the adenosine A1 receptor antagonist rolofylline on renal function in patients with acute heart failure and renal dysfunction: results from PROTECT (Placebo-Controlled Randomized Study of the Selective Adenosine A1 Receptor Antagonist Rolofylline for Patients Hospitalized with Acute Decompensated Heart Failure and Volume Overload to Assess Treatment Effect on Congestion and Renal Function).
    Voors AA; Dittrich HC; Massie BM; DeLucca P; Mansoor GA; Metra M; Cotter G; Weatherley BD; Ponikowski P; Teerlink JR; Cleland JG; O'Connor CM; Givertz MM
    J Am Coll Cardiol; 2011 May; 57(19):1899-907. PubMed ID: 21545947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beyond diuretics: management of volume overload in acute heart failure syndromes.
    Hill JA; Yancy CW; Abraham WT
    Am J Med; 2006 Dec; 119(12 Suppl 1):S37-44. PubMed ID: 17113399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of nesiritide and predictors of urine output in acute decompensated heart failure: results from ASCEND-HF (acute study of clinical effectiveness of nesiritide and decompensated heart failure).
    Gottlieb SS; Stebbins A; Voors AA; Hasselblad V; Ezekowitz JA; Califf RM; O'Connor CM; Starling RC; Hernandez AF
    J Am Coll Cardiol; 2013 Sep; 62(13):1177-83. PubMed ID: 23747790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intensification of Medication Therapy for Cardiorenal Syndrome in Acute Decompensated Heart Failure.
    Grodin JL; Stevens SR; de las Fuentes L; Kiernan M; Birati EY; Gupta D; Bart BA; Felker GM; Chen HH; Butler J; Dávila-Román VG; Margulies KB; Hernandez AF; Anstrom KJ; Tang WH
    J Card Fail; 2016 Jan; 22(1):26-32. PubMed ID: 26209004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current Approach to Decongestive Therapy in Acute Heart Failure.
    Martens P; Nijst P; Mullens W
    Curr Heart Fail Rep; 2015 Dec; 12(6):367-78. PubMed ID: 26486631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is Time of the Essence? The Impact of Time of Hospital Presentation in Acute Heart Failure: Insights From ASCEND-HF Trial.
    Cerbin LP; Ambrosy AP; Greene SJ; Armstrong PW; Butler J; Coles A; DeVore AD; Ezekowitz JA; Hernandez AF; Metra M; Starling RC; Tang W; Teerlink JR; Voors AA; Wu A; O'Connor CM; Mentz RJ
    JACC Heart Fail; 2018 Apr; 6(4):298-307. PubMed ID: 29525328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances in chemical pharmacotherapy for managing acute decompensated heart failure.
    Yandrapalli S; Tariq S; Aronow WS
    Expert Opin Pharmacother; 2017 Apr; 18(5):471-485. PubMed ID: 28276970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting the kidney in acute decompensated heart failure: conventional diuretics and renal-acting vasodilators.
    Martin FL; Chen HH; Cataliotti A; Burnett JC
    Rev Cardiovasc Med; 2008; 9(1):39-45. PubMed ID: 18418308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nesiritide: a review of its use in acute decompensated heart failure.
    Keating GM; Goa KL
    Drugs; 2003; 63(1):47-70. PubMed ID: 12487622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The management of acute heart failure and diuretic therapy.
    Somberg JC; Molnar J
    Am J Ther; 2009; 16(1):93-7. PubMed ID: 19142155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short-term clinical effects of tolvaptan, an oral vasopressin antagonist, in patients hospitalized for heart failure: the EVEREST Clinical Status Trials.
    Gheorghiade M; Konstam MA; Burnett JC; Grinfeld L; Maggioni AP; Swedberg K; Udelson JE; Zannad F; Cook T; Ouyang J; Zimmer C; Orlandi C;
    JAMA; 2007 Mar; 297(12):1332-43. PubMed ID: 17384438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vasodilators in acute heart failure - evidence based on new studies.
    Travessa AM; Menezes Falcão L
    Eur J Intern Med; 2018 May; 51():1-10. PubMed ID: 29482882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute decompensated heart failure: contemporary medical management.
    Joseph SM; Cedars AM; Ewald GA; Geltman EM; Mann DL
    Tex Heart Inst J; 2009; 36(6):510-20. PubMed ID: 20069075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute decompensated heart failure: best evidence and current practice.
    Mehta R; Feldman D
    Minerva Cardioangiol; 2005 Dec; 53(6):537-47. PubMed ID: 16333237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.